By Erik Larson ( October 24, 2005, 12:00 AM EDT) -- The contentious "wildcard" provision for market exclusivity has been removed prior to a vote from an updated Biodefense bill on Capitol Hill, easing concerns of the generic drug industry while leaving intact other controversial language....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.